Is the Minimally Important Difference Really 0.50 of a Standard Deviation? Ron D. Hays, Ph.D. June 18, 2004.

Slides:



Advertisements
Similar presentations
An Overview of Minimally Important Difference Estimation in Health-Related Quality of Life Studies Ron D. Hays, Ph.D. October 14, 2004,
Advertisements

ASSESSING RESPONSIVENESS OF HEALTH MEASUREMENTS. Link validity & reliability testing to purpose of the measure Some examples: In a diagnostic instrument,
15-minute Introduction to PROMIS Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research Roundtable Meeting on Measuring.
Effects of Mode and Order of Administration on Generic HRQOL Scores? Ron D. Hays, Seong Eun Kim, Karen Spritzer, and Honghu Liu UCLA 1:00-2:00 pm.
What is going on with psychotherapy today? Carolyn R. Fallahi, Ph. D.
Statistical Issues in Research Planning and Evaluation
Why Patient-Reported Outcomes Are Important: Growing Implications and Applications for Rheumatologists Ron D. Hays, Ph.D. UCLA Department of Medicine RAND.
How Much Improvement in Functional Status Is Considered Important by Patients With Active Psoriatic Arthritis: Applying the Outcome Measures in Rheumatoid.
Cross-Cultural Use of Measurements: Development of the Chinese SF-36 Health Survey Xinhua S. Ren, Ph.D. Boston University School of Public Health, Boston,
Meta-analysis & psychotherapy outcome research
1 8/14/2015 Evaluating the Significance of Health-Related Quality of Life Change in Individual Patients Ron Hays October 8, 2004 UCLA GIM/HSR.
1 Health-Related Quality of Life Ron D. Hays, Ph.D. - UCLA Department of Medicine: Division of General Internal Medicine.
Basic Methods for Measurement of Patient-Reported Outcome Measures Ron D. Hays, Ph.D. UCLA/RAND ISOQOL Conference on.
“A Critical Look at Health-Related Quality of Life Measures” SGIM Annual Meeting Ron D. Hays May 2, 2003 (12:30-1:30 pm)
Quality Measures for Rehabilitation: Policy, Provider and Patient Perspectives Measuring Clinical Change: Quality Indicators ACRM-ASNR Pre-Conference Institute.
Measuring Health Outcomes
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients Assessment.
University of Minnesota Medical Technology Evaluation and Market Research Department of Healthcare Management Course: MILI/PUBH 6589 Spring Semester, 2013.
Introduction Patients with tumors affecting the spine have significant impairments in Quality of Life domains that include physical function, neural function,
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.
Use of Health-Related Quality of Life Measures to Assess Individual Patients July 24, 2014 (1:00 – 2:00 PDT) Kaiser Permanente Methods Webinar Series Ron.
Health-Related Quality of Life as an Indicator of Quality of Care May 4, 2014 (8:30 – 11:30 PDT) HPM216: Quality Assessment/ Making the Business Case for.
1 Assessing the Minimally Important Difference in Health-Related Quality of Life Scores Ron D. Hays, Ph.D. UCLA Department of Medicine October 25, 2006,
1 10/19/2015  Course materials copyrighted 2003 by Ron D. Hays A Comprehensive Approach to the Measurement of Health Outcomes Ron D. Hays, Ph.D. UCLA.
EBC course 10 April 2003 Critical Appraisal of the Clinical Literature: The Big Picture Cynthia R. Long, PhD Associate Professor Palmer Center for Chiropractic.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
Evaluating Health-Related Quality of Life Measures June 12, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series Ron D.Hays, Ph.D.
CM Implementation and Analysis of PROs in Clinical Trials DIA Meeting, D.C., June 26, 2005 Jeff A. Sloan, Ph.D.
Measuring Health-Related Quality of Life Ron D. Hays, Ph.D. UCLA Department of Medicine RAND Health Program UCLA Fielding School of Public Health
Development of Physical and Mental Health Summary Scores from PROMIS Global Items Ron D. Hays ( ) UCLA Department of Medicine
Measuring Health-Related Quality of Life
Are Positive Experiences with Health Care Bad for Health? June 14, 2015 (AcademyHealth) Minneapolis Convention Center 1301 S. 2nd Avenue, Minneapolis,
1 Finding and Verifying Item Clusters in Outcomes Research Using Confirmatory and Exploratory Analyses Ron D. Hays, PhD May 13, 2003; 1-4 pm; Factor
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
Medical Statistics as a science
1 Session 6 Minimally Important Differences Dave Cella Dennis Revicki Jeff Sloan David Feeny Ron Hays.
KNR 445 Statistics t-tests Slide 1 Introduction to Hypothesis Testing The z-test.
Evaluating Self-Report Data Using Psychometric Methods Ron D. Hays, PhD February 6, 2008 (3:30-6:30pm) HS 249F.
EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)
Introduction ESTIMATING THE MINIMALLY IMPORTANT DIFFERENCE (MID) OF THE DIABETES HEALTH PROFILE (DHP-18) FOR TYPE 1 AND TYPE 2 DIABETES MELLITIS Brendan.
Assessing Responsiveness of Health Measurements Ian McDowell, INTA, Santiago, March 20, 2001.
Evaluating Self-Report Data Using Psychometric Methods Ron D. Hays, PhD February 8, 2006 (3:00-6:00pm) HS 249F.
Introducing Structural Equation Modeling (SEM) to Novices Using Kevin Heslin's SF-36 Data from Opioid Users Ron D. Hays, Ph.D. May 8, 2009, 12:01-12:59pm.
The Impact Factor (IF): What Is It Good For? Richard M. Rocco, PhD October
Approaches for Estimating Minimally Important Differences Ron D. Hays, Ph.D. January 12, 2004 (8:50-9:10am) Minimal Clinically Important Differences in.
Quality of life and its health- relations. Definitions.
Can patients be satisfied to death? What was Joshua J. Fenton thinking? Ron D. Hays, Ph.D. July 21, 2015 UCLA Center for Maximizing Outcomes and Research.
Measurement of Outcomes Ron D. Hays Accelerating eXcellence In translational Science (AXIS) January 17, 2013 (2:00-3:00 pm) 1720 E. 120 th Street, L.A.,
Highlights of Current Research Ron Hays UCLA GIM/HSR Introduction to Fellows August 10, 2007 ~ 12:19 pm.
Patient-Reported Physical Functioning Ron D. Hays November 27, 2012 (11:15-11:30) UCLA Department of Medicine MCID for Orthopaedic Devices Silver Springs,
Evaluating Health-Related Quality of Life Measures Ron D. Hays, Ph.D. UCLA GIM & HSR February 9, 2015 (9:00-11:50 am) HPM 214, Los Angeles, CA.
Impact of using a next button in a web-based health survey on time to complete and reliability of measurement Ron D. Hays (Rita Bode, Nan Rothrock, William.
Estimating Minimally Important Differences on PROMIS Domain Scores Ron D. Hays UCLA Department of Medicine/Division of General Internal Medicine & Health.
Evaluating Multi-Item Scales Health Services Research Design (HS 225B) January 26, 2015, 1:00-3:00pm CHS.
Health-Related Quality of Life in Outcome Studies Ron D. Hays, Ph.D UCLA Division of General Internal Medicine & Health Services Research GCRC Summer Session.
Health-Related Quality of Life (HRQOL) Assessment in Outcome Studies Ron D. Hays, Ph.D. UCLA/RAND GCRC Summer Course “The.
Neurologic Effects Associated With Efavirenz Generally Mild, Transient Slideset on: Clifford DB, Evans S, Yang Y, et al. Impact of efavirenz on neuropsychological.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Health-Related Quality of Life After Carotid Stenting.
NIH: Patient-Reported Outcomes Measurement Information System (PROMIS®) Ron D. Hays Functional Vision and Visual Function November 10, 2016, 8:55-9:15am.
The Minimal Important Difference for St
Presenter: Corina de Jong PhD Department of General Practice,
Health-Related Quality of Life Assessment in Outcome Studies
Rhematoid Rthritis Respiratory disorders
Estimating Minimally Important Differences (MIDs)
Introduction to Psychometric Analysis of Survey Data
Evaluating the Significance of Individual Change
GIM & HSR Research Seminar: October 5, 2018
UCLA Department of Medicine
Patient-reported Outcome Measures
Presentation transcript:

Is the Minimally Important Difference Really 0.50 of a Standard Deviation? Ron D. Hays, Ph.D. June 18, 2004

2 Some Key Citations u Crosby, R.D., Kolotkin, R.L., & Williams, G.R. (2003). Defining clinically meaningful change in health-related quality of life. J Clin Epi., 56, u Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care, 41 (5), u Farivar, S. S., Liu, H., & Hays, R. D. (in press). Another look at the half standard deviation estimate of the minimally important difference in health-related quality of life scores. Pharmacoeconomics and Outcomes Research. u

3 Minimally Important Difference (MID) u One can observe a difference between two groups or within one group over time that is statistically significance, but the difference could be small. u With a large enough sample size, even a tiny difference could be statistically significant. u The MID is the smallest difference that we care about. u Focus is on scale

4 Clinical Significance in Psychology Literature u “The status of a patient is characterized as clinically significantly changed when the client’s level of measured functioning is located in the nonfunctional range at the beginning of treatment and in the functional range at the end of treatment, if that change is statistically reliable” (Bauer et al., J Personality Assessment, 2004, p. 61). u Focus is on the individual

5 Without Specific Information about Scale MID, We Rely on Effect Size Benchmarks Small: 0.20->0.49 Moderate: 0.50->0.79 Large: 0.80 or above

6 Distribution-Based “Estimation” of MID u Provides no direct information about the MID –Effect size (ES) = D/SD –Standardized Response Mean (SRM) = D/SD † –Guyatt responsiveness statistic (RS) = D/SD ‡ D = raw score change in “changed” group; SD = baseline SD; SD † = SD of D; SD ‡ = SD of D among “unchanged”

7 Estimating the MID u External anchor to determine there has been “minimal” change –Self-report –Provider report –Clinical measure –Intervention u Estimate change in HRQOL among those with minimal change on anchor

8 Terminology Minimally Important Difference (MID) -> Minimally Detectable Difference (MDD) -> Clinically Important Difference (CID) Obviously Important Difference (OID)

9 Self-Report Anchor u People who report a “minimal” change u How is your physical health now compared to 4 weeks ago? u Much improved; Moderately Improved; u Minimally Improved; u No Change; u Minimally Worse; u Moderately Worse; Much Worse

10 Example with Multiple Anchors u 693 RA clinical trial participants evaluated at baseline and 6-weeks post-treatment. u Five anchors: –1) patient global self-report; –2) physician global report; –3) pain self-report; –4) joint swelling; –5) joint tenderness Kosinski, M. et al. (2000). Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis. Arthritis and Rheumatism, 43,

11 Patient and Physician Global Reports u How the patient is doing, considering all the ways that RA affects him/here? Very good (asymptomatic and no limitation of normal activities) Good (mild symptoms and no limitation of normal activities) Fair (moderate symptoms and limitation of normal activities) Poor (severe symptoms and inability to carry out most normal activities) Very poor (very severe symptoms that are intolerable and inability to carry out normal activities) --> Improvement of 1 level over time

12 Global Pain, Joint Swelling and Tenderness u Global Pain –10 centimeter visual analog scale – 0 = no pain, 10 = severe pain u Number of swollen and tender joints -> 1-20% improvement over time

13 Norman, Sloan, Wyrwich (2003) u “Interpretation of Changes in Health-related Quality of Life: The remarkable universality of half a standard deviation” u Table 1 reports estimates of MIDs for 33 published articles.“For all but 6 studies, the MID estimates were close to one half a SD (mean = 0.495, SD = 0.155)” (p. 582).

14 Why not accept 0.50 SD as MID? u Based on 33 published articles. –While 33 may seem like a large number of studies, not really a very large sample size for statistical analysis. u Problems with Norman et al. paper –Included an article based on a 6-minute walk test –Included articles with anchors that did not necessarily represent minimal change –Selective reporting of HRQOL results –Included articles with no estimates of MID u Wide variation in estimates of MID

15 Six-minute Walk Test is not HRQOL u Studied 112 people with stable COPD. Norman et al. reported an ES of 0.43 ( ) for 6-minute walk test based on a comparison of “about the same” versus “a little better” and “about the same” with “a little bit worse.” Redelmeier et al. (1997)

16 Why not accept 0.50 SD as MID? u Problems with Norman et al. paper –Included an article based on a 6-minute walk test –Included articles with anchors that did not necessarily represent minimal change –Selective reporting of HRQOL results –Included articles with no estimates of MID u Wide variation in estimates of MID

17 Getting Hit By Bike is > Minimal Getting Hit by Rock is Closer to MID

18 Mean Scores of NEI RQL Scales Before and After Surgery (n = 185)

19 Anchor doesn’t represent minimal change u Looked at change on MOS-HIV and MQOL-HIV in 296 persons with AIDS who improved (better and much better)--not an estimate of MID. Badia et al. (2000)

20 Why not accept 0.50 SD as MID? u Problems with Norman et al. paper –Included an article based on a 6-minute walk test –Included articles with anchors that did not necessarily represent minimal change –Selective reporting of HRQOL results –Included articles with no estimates of MID u Wide variation in estimates of MID

21 Anchor Doesn’t Represent Minimal Change (Also Selective Reporting) u Estimated change in RQLQ (ES = 0.48) for 19 new rhinitis patients before and after seeing an allergist who prescribed a new medication regimen. u Don’t know magnitude of the intervention. u In addition, SF-36 data not included. Average ES for SF-36 was Bagenstowe and Bernstein

22 Why not accept 0.50 SD as MID? u Problems with Norman et al. paper –Included an article based on a 6-minute walk test –Included articles with anchors that did not necessarily represent minimal change –Selective reporting of HRQOL results –Included articles with no estimates of MID u Wide variation in estimates of MID

23 ES derived from assumed MID differences u Wyrwich et al. (1999) studied 605 CAD/CHF patients and Wyrwich et al. (1999) evaluated 417 COPD patients. No anchors were used in these studies. u ES of 0.36 and 0.35 for the CHQ and CRQ were based on previously reported MID recommendations. u ES = 0.35 for CRQ = 0.5 MID guideline/SD in sample of 417 COPD patients.

24 Why not accept 0.50 SD as MID? u Problems with Norman et al. paper –Included an article based on a 6-minute walk test –Included articles with anchors that did not necessarily represent minimal change –Selective reporting of HRQOL results –Included articles with no estimates of MID u Wide variation in estimates of MID

25 Wide variation in MID estimates u Median of the mean ES for studies was u Range = 0.11 to 2.31 u SD of mean ES = 0.31 u Coefficient of variation = 64%

26 Effect Sizes (mean = 0.34) for SF-36 Changes Linked to Minimal Change in Anchors ScaleSelf-RClin.-RPainSwellTenderMean PF Role-P Pain GH EWB Role-E SF EF PCS.49< MCS.42<

27 Conclusions and Recommendations for Estimating the MID u It is easier to conclude that a difference is clearly or obviously important than it is to say one is always unimportant. u Best way to estimate MID –Use multiple anchors –Use anchors that represent minimum change u Because of variation in estimates of MID –Report range, inter-quartile range, and confidence intervals around mean estimates.

28 Preparation for this presentation was supported in part by funding from the UCLA/DREW Project EXPORT, National Institutes of Health, National Center on Minority Health & Health Disparities, (P20-MD ) and the UCLA Center for Health Improvement in Minority Elders / Resource Centers for Minority Aging Research, National Institutes of Health, National Institute of Aging, (AG ).

29 Appendix Slides

30 Interpreting Data with Control Group: MID = ? Change #1 Control group - 4 Intervention Group 0

31 Interpreting Data with Control Group: MID is ? Change #2 Control group + 2 Intervention Group + 2

32 Interpreting Data with Control Group: MID = 4 Change #3 Control group + 2 Intervention Group + 4

33 Summary of Interpreting Data with Control Group Change #1Change #2Change #3 Control Intervention

34 Standard Error of Measurement u SEM = SD * SQRT (1-reliability) u 1 SEM = 0.50 SD when reliability is 0.75

35 Example Use of Self-Report Anchor in COPD u Compared to Jack, my ability to walk is: –Much better; Somewhat better; A little bit better; About the same; A little bit worse; Somewhat worse; Much worse u Determined how much actual walking distance had to differ, on average, for patients to rate themselves as walking either a little bit better or a little bit worse. Redelmeier, D. A. et al., 1997, Am J Respir Crit Care Med